Fall Prevention Program for Non-ambulatory Wheeled Mobility Device Use
Validation of a Fall Prevention Program Among Non-Ambulatory Wheeled Mobility Device Users With Multiple Sclerosis
What it found
A paper reports the results; we have not read it yet. See Papers below.
What was tested
Treatment tested
- Fall Management program
What it measured
Main measures
Reduction in fall incidence
44 weeks
Walking and mobility
Other measures (3)
Management of Fall
44 weeks
Walking and mobilityPrevention of Fall
44 weeks
Walking and mobilityPrevention and Management of Fall
44 weeks
Walking and mobility
Who could take part
MS (type not specified) · 18 and over
Show the full criteria
Inclusion criteria
1. Diagnosis of Multiple Sclerosis 2. >18 years old 3. Main form of mobility is via a wheeled mobility device (Patient Determined Disease Steps Level 7) 4. Self reported ability to transfer with moderate assistance or less 5. Self-reported fall history (at least 1 fall/12 months)
Exclusion criteria
1. MS exacerbation in the past 30 days 2. Received a score of 10 or above to the Short Blessed Test (attached) 3. Inability to sit upright for at least 1 hour.
As registered. Criteria can change, so ask the trial team or your neurologist.
About this trial
In the sponsor's words
A research study to examine the effectiveness of a fall management program to prevent falls and develop fall recovery strategies for wheeled mobility device users living with Multiple Sclerosis.
Papers
Results
Validation of an individualized reduction of falls intervention program among wheelchair and scooter users with multiple sclerosis.Medicine (Baltimore) · 2019
Loading reviews and guidelines…
History
Started
Mar 2018
Main results due
Jan 2020
Finished
Jan 2020